Skip to main content
MarketTriage

MarketTriage Weekly

Salesforce's big beat was mostly a windfall

Week ending 2026-08-28

Market cycle distribution — regime counts across the 5 cycle zones

The 30-second read

What changed: Salesforce's $5.90 profit included a $2.53 one-off gain; 65 of 389 stocks sit in Caution.

One stock to watch: $CRM: headline earnings met an already-extended chart.

What to think about: Whether next week's $AVGO report confirms or breaks the AI-hardware story.

Market Health Check

Market health gauges: Credit healthy, Volatility calm, Breadth mixed, Rates curve normal, Sentiment complacent

The risk this week sits inside the market, not around it.

The high-yield ratio holds above its long-term average and VIX (the market's fear gauge) at 14.41 sits under its 17.48 three-month reading, so financing conditions give the advance room to run. Participation is the weak link, with 60% of US equities above their 50-day average and bulls at 33% against 44% bears, and next week's earnings cluster is what tests that gap.

Triage Board Weekly

11 sector ETFs positioned across the market cycle from STABLE to BREAKDOWN
Each dot is one of the 11 S&P sector ETFs at its current regime.

Sector pulse: Cycle and relative-strength leadership are aligned, but the board still separates that support from names showing fatigue.

CLEARANCE
$BACBank of America

Announced $250bn critical-infrastructure finance initiative.

$PINSPinterest Inc.

The stock reclaimed its 50-day and 200-day averages as three funds added and one trimmed.

OBSERVATION
$DASHDoorDash

Q2 outlook highlighted Deliveroo integration and margins.

$MSFTMicrosoft Corporation

Reclaimed both moving averages; a recent pivot high remains overhead.

CAUTION
$MAMastercard

Completed BVNK acquisition for stablecoin payments.

$NETCloudflare

Q2 revenue grew 36%; remaining contracted revenue grew 35%.

→ Set Telegram alerts for regime transitions in your watchlist

Signal Spotlight

Signal spotlight card for CRM

Open $CRM on the live dashboard →

Salesforce ($CRM) — OBSERVATION · Strong signal

Salesforce's headline beat came from its investment portfolio, not from selling software. Analysts wanted $3.27 a share and got $5.90; a strategic-investment gain supplied 96% of the $2.63 difference. Revenue itself topped estimates by 0.13%, a rounding error.

The strength label above rates the breakout, not the buy point; overbought and near its highs, Salesforce doesn't offer a clean entry. Claudeforce, which wires Claude into Salesforce data, opens to beta users in September.

Position Trader Playbook

An earnings gap earns trust with time, not with the first few sessions. The test is whether price still holds the level it broke above weeks later, on ordinary volume. Holding on ordinary volume means real buyers replaced the event crowd; slipping back through it means they never arrived.

Latest News

Salesforce reported second-quarter results on 2026-08-26 and gapped higher the following session.

Contracted revenue due within 12 months grew 14% in constant currency, faster than recognised revenue.

Claudeforce, which connects Claude to Salesforce data, enters open beta in September.
Full-year guidance rose, though part of the increase comes from pending acquisitions rather than the existing business.

Institutional Context

Wall Street raised its numbers without reaching agreement. Post-earnings targets run from Wells Fargo at $230, below the current price, to Truist at $300. Only one of 22 analysts lifted estimates over the past 30 days, and none cut.
13F filings (big funds' quarterly holdings) name Citadel trimming in the second quarter, with no fund adding. That read predates the gap, so it says nothing about who bought it.

Macro Alignment

• VIX is 14.41 against a 17.48 three-month reading, so no stress is priced.

• Credit conditions are supportive, with no macro pause active.

• Technology sits in the improving quadrant, not yet leading the market.

Technical Picture

• Relative strength reached a three-month high, but not a 52-week high.

• Weekly volume has run 1.68 times normal across the advance.

• Price stands 27.8% above its 200-day average, with RSI (momentum gauge) at an overbought 80.8.

What to Watch

Setup invalidated if: Price closes below $200.32, its 200-day average.

Thesis intact while: Price holds the $254.48 breakout level on ordinary volume.

Next data point: The $269.11 52-week high, 4.9% above, is the next real test.

Institutional Activity

Insiders · executives lock in gains

$DDOG Datadog: 13 executives (CEO, Director, CTO) sold $311M.

Big-stake filings · Cox discloses a large stake

$CHTR Charter Communications, Inc.: Cox Enterprises filed 13D for 27.9% (Aug 25).

Whale · Q2 holdings (as of Jun 30): buyers outnumber sellers

$NVDA NVIDIA Corporation: net buying, 7 funds added versus 4 (Renaissance, Bridgewater).

Futures positioning · sellers retain the upper hand

$UNG Natural Gas: depressed positioning tracks an 11.51% 63-day decline.

Share the read → Forward this to a fellow trader, or share this issue online →

On The Radar

Next 7 Days

2026-09-02

$HPE, $CRDO, $DELL and $PANW earnings.

2026-09-03

$SNOW, $AVGO and $LULU earnings.

2026-09-04

Weekly futures-positioning report.

→ View the full live pipeline

None of the above is a recommendation to buy or sell any security.